Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma (Q35788884)
Jump to navigation
Jump to search
scientific article published on 19 August 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma |
scientific article published on 19 August 2014 |
Statements
1 reference
Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma (English)
1 reference
David Mathieu
1 reference
David A Reardon
1 reference
Louis B Nabors
1 reference
Warren P Mason
1 reference
James R Perry
1 reference
William Shapiro
1 reference
Petr Kavan
1 reference
Surasak Phuphanich
1 reference
Agnieszka Cseh
1 reference
Yali Fu
1 reference
Julie Cong
1 reference
Sven Wind
1 reference
David D Eisenstat
1 reference
BI 1200 36 Trial Group and the Canadian Brain Tumour Consortium
1 reference
19 August 2014
1 reference
1 reference
17
1 reference
3
1 reference
430-439
1 reference
Identifiers
1 reference
1 reference
1 reference